Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...
Company Transitions from Infrastructure Buildout to Active Market Execution as Expanded 510(k) Review Enters Final ...
The U.S. Food and Drug Administration (FDA) has again missed a deadline to propose a ban on chemicals in hair-straightening ...
With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits.
A handful of other states are considering mandating private insurance coverage of the technology, used to block ...
Expanded authorization enables AI-guided FoCUS across devices—supporting consistent diagnostic-quality imaging and ...
BrightHeart delivers expert-level ultrasound screening for complex organs, helping OB-GYNs improve the detection of ...
The company’s new AI agent automates labor-intensive processes involved in trial document management.
A 2023 study found that red light therapy stimulated the hair follicle for visibly thicker hair, increasing hair growth rate ...
inews.co.uk on MSN
I lost 8st on weight-loss jabs - but I am devastated by the aftermath
Rosie Parsons dropped from around 19st to 11st with the help of weight-loss drugs. But after she stopped, the cravings came ...
Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...
Rare diseases, defined by FDA as “a disease or condition that affects less than 200,000 people in the United States” (1), may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback